Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0129966 PRODUCTION OF FC FRAGMENTS
In one aspect, the disclosure provides cells and transgenic non-human mammals for the production of Fc fragments, as well as compositions and uses thereof.
2017/0129965 IgE ANTIBODIES FOR THE INHIBITION OF TUMOR METASTASIS
The present invention provides novel IgE antibodies useful for inhibiting or preventing metastatic cancer. Also provided are methods to inhibit tumor...
2017/0129964 USES OF MONOCLONAL ANTIBODY 8H9
This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention...
2017/0129963 COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those...
2017/0129962 MULTISPECIFIC ANTIBODIES
The present invention relates to multispecific antibodies, methods for their production, pharmaceutical compositions containing said antibodies and uses thereof.
2017/0129961 ANTIBODY CONSTRUCTS FOR CD70 AND CD3
The present invention relates to a bispecific antibody construct comprising a first binding domain which binds to human CD70 on the surface of a target cell...
2017/0129960 HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR
The present invention provides antibodies that bind to the human glucagon receptor, designated GCGR and methods of using same. According to certain embodiments...
2017/0129959 Antibodies Directed Against CD127
The invention relates to antibodies directed against CD127, the alpha chain of the interleukin 7 (IL-7) receptor IL-7R), and which have antagonist properties...
2017/0129958 COMBINATION THERAPY
Combination of human antibodies that bind to human platelet-derived growth factor receptor alpha (PDGFR alpha), preferably olaratumab, and doxorubicin as a...
2017/0129957 ANTI-AXL ANTIBODIES
Antibodies characterized by their variable sequences/CDRs which specifically bind to the Axl protein are described. Also disclosed are methods for the...
2017/0129956 ANTI-SIGLEC-15 ANTIBODIES FOR USE IN TREATMENT OF OSTEOGENESIS IMPERFECTA
The present invention relates to the treatment of osteogenesis imperfecta with anti-Siglec-15 antibodies or antigen binding fragment thereof. Treatment of...
2017/0129955 ALPHA-V BETA-8 ANTIBODIES
Provided herein are antibodies specific for integrin .alpha.v.beta.8 that change the conformation of .beta.8 so that, upon binding the ability of ...
2017/0129954 Use of Anti-MCAM Antibodies for Treatment or Prophylaxis of Giant Cell Arteritis, Polymyalgia Rheumatica or...
The invention provides anti-MCAM antibodies that inhibit the ability of human MCAM to bind a laminin alpha-4 chain and pharmaceutical compositions and...
2017/0129953 A METHOD OF TREATING BONE DISEASE
The disclosure provides compositions and methods comprising a sialoadhesin binding moiety for treating metabolic and genetic bone disease, especially for...
2017/0129952 METHOD OF REDUCING PRURITUS USING IL-31 MONOCLONAL ANTIBODIES
The present invention relates to methods of treating pruritic diseases, including but not limited to Contact dermatitis, Atopic Dermatitis, Drug induced...
2017/0129951 NOVEL HUMAN CONTROL ANTIBODIES AND USES THEREFOR
The present invention provides novel, rationally designed human control antibodies for use in various in vivo and in vitro applications. The antibodies of the...
2017/0129950 Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
The inventors successfully produced anti-Epiregulin antibodies showing cross-species reactivity between cynomolgus monkey (non-human animals) and human,...
2017/0129949 HUMANIZED ANTI-Tau(pS422) ANTIBODIES AND METHODS OF USE
The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.
2017/0129947 REGULATING THE INTERACTION BETWEEN TAM LIGANDS AND LIPID MEMBRANES WITH EXPOSED PHOSPHATIDYL SERINE
The present disclosure provides methods for modulating the interaction between a TAM ligand and a lipid membrane containing phosphatidyl serine (PtdSer). In...
2017/0129946 HMG1 Antibody For Treating Inflammatory Conditions
There is disclosed a pharmaceutical composition and method for treating sepsis, including septic shock and ARDS (acute respiratory distress syndrome),...
2017/0129945 POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY
The invention relates to polypeptides that comprise a portion of filamentous bacteriophage gene 3 protein (g3p) sufficient to bind to and/or disaggregate...
2017/0129944 METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
A new use of a molecule comprising at least one moiety which is a biologically active protein and at least one moiety capable of binding to a serum albumin of...
2017/0129943 TREATMENT OF POLYBACTERIAL INFECTIONS
Provided herein are methods of preventing and treating polybacterial infections comprising administering an effective amount of an antibody or antigen-binding...
2017/0129942 ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used...
2017/0129941 H. Pylori Lipopolysaccharide Outer Core Epitope
Helicobacter pylori, one of the most common human pathogens, is associated with the development of human chronic gastritis, peptic ulcers and gastric cancer....
2017/0129940 HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and...
2017/0129939 HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF
The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and...
2017/0129938 PRODUCTION OF RECOMBINANT VON WILLEBRAND FACTOR IN A BIOREACTOR
The present invention relates to improved methods for the recombinant production of von Willebrand factor (vWF) in a bioreactor by separating different...
2017/0129937 MAMMALIAN CELL CULTURE PROCESSES FOR PROTEIN PRODUCTION
The present invention describes methods and processes for the production of proteins, particularly glycoproteins, by animal cell or mammalian cell culture,...
2017/0129935 METHOD FOR PURIFYING TERIPARATIDE
The present invention relates to a novel method for purifying teriparatide, a therapeutically active polypeptide fragment of full-length human parathyroid...
2017/0129934 NATRIURETIC POLYPEPTIDES
This document provides methods and materials related to natriuretic polypeptides and the use of natriuretic polypeptides to treat cardiovascular and/or renal...
2017/0129933 PURIFICATION OF TGF-BETA SUPERFAMILY PROTEINS
Methods of purifying TGF-.beta. superfamily proteins, including osteogenic proteins such as bone morphogenetic proteins (BMPs), are disclosed.
2017/0129932 METHOD FOR PREPARING RECOMBINANT GLYCOPROTEIN HAVING HIGH SIALIC ACID CONTENT, THROUGH GLYCOSPHINGOLIPID...
The present invention relates to a method for preparing a recombinant cell line producing recombinant glycoproteins having a high sialic acid content by...
2017/0129931 Modified Latency Associated Protein Construct
The present invention provides a fusion protein comprising a latency associated peptide (LAP), a pharmaceutically active agent and an amino acid sequence...
2017/0129930 COMPOSITIONS AND METHODS FOR MODULATING NEURONAL DEGENERATION
The present disclosure provides genetically modified animals and cells comprising a polynucleotide encoding human profilin1. Also provided are methods of...
2017/0129929 LEDGF PEPTIDES AND FORMULATIONS THEREOF FOR TREATMENT OF DEGENERATIVE DISORDERS
LEDGF peptides with anti-protein aggregation activity and methods of use are provided. The LEDGF peptides disclosed herein demonstrate an ability to treat...
2017/0129928 Preparation Methods for a Novel Generation of Biological Safe KLH Products Used for Cancer Treatment, for the...
The present invention relates to the provision of a biologically safe hemolymph sera, preferably hemocyanin, more preferably KLH (keyhole limpet hemocyanin). A...
2017/0129927 CYSTINE KNOT SCAFFOLD PLATFORM
Provided are non-naturally occurring cystine knot peptides (CKPs) that bind to VEGF-A. Additionally, provided are methods of using non-naturally occurring CKPs...
2017/0129926 New Polypeptide
The present disclosure relates to complex comprising an engineered polypeptide having affinity for interleukin-6 (in the following referred to as IL-6) and an...
2017/0129925 PROCESS OF PREPARING GUANYLATE CYCLASE C AGONISYS
The invention provides processes of preparing a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-249 described herein.
2017/0129924 PEPTIDES WITH ANTIMICROBIAL, ANTICANCER AND/OR WOUND-HEALING PROMOTING ACTIVITIES, PHARMACEUTICAL COMPOSITIONS...
A peptide with antimicrobial, anticancer and/or wound-healing promoting activities is provided. The peptide with antimicrobial, anticancer and/or wound-healing...
2017/0129923 GrB-EHITSN Inhibitory Peptides
Fusion peptides and methods of inhibiting GrB-EHITSN or a fragment thereof are provided. The fusion peptides include an NPF peptide and a cell-permeable...
2017/0129922 AFFINITY PEPTIDE LIGAND OF MOUSE POLYOMAVIRUS CAPSOMER AND DESIGNED SCREENING METHOD THEREOF
Affinity peptide ligands of mouse polyomavirus capsomers and a designed screening method thereof. The affinity peptide ligands can be used for separation and...
2017/0129921 DISCOVERY OF THE FIRST SELECTIVE C5A2 RECEPTOR (C5L2/C5AR2) LIGANDS
A method of selectively modulating the activity of C5a receptor 2 (C5aR2). The method includes exposing the receptor to a compound that selectively modulates...
2017/0129920 Process for Preparing D-Arginyl-2,6-Dimethyl-L-Tyrosyl-L-Lysyl-L-Phenylalaninamide
The invention relates to a process for solution-phase synthesis of D-Arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide, an active ingredient used for...
2017/0129919 CYCLIC DIPEPTIDE-CONTAINING COMPOSITION
A cyclic dipeptide-containing composition containing each of tyrosine-containing cyclic dipeptides selected from the group consisting of...
2017/0129918 SELECTIVE PHOTOACTIVATION OF AMINO ACIDS FOR SINGLE STEP PEPTIDE COUPLING
Disclosed herein are formulations, substrates, and arrays for amino acid and peptide synthesis on microarrays. In certain embodiments, methods for ...
2017/0129917 NOVEL BETULINIC PROLINE IMIDAZOLE DERIVATIVES AS HIV INHIBITORS
The present invention relates to novel betulinic proline imidazole derivatives and related compounds, compositions useful for therapeutic treatment of viral...
2017/0129916 NOVEL BETULINIC PROLINE IMIDAZOLE DERIVATIVES AS HIV INHIBITORS
The invention relates to novel betulinic proline substituted derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic...
2017/0129915 THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH NERVE AXON DYSFUNCTION, INCLUDING THERAPEUTIC AGENT FOR...
Provided are a clinically applicable drug for radical cure of Alzheimer's disease (AD), and a drug for treating neurological diseases associated with axonal...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.